Total Artificial Heart Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Total Artificial Heart Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Total Artificial Heart Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Total Artificial Heart pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Total Artificial Heart under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Total Artificial Heart and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Total Artificial Heart under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Total Artificial Heart Overview
  • Products under Development
    • Total Artificial Heart - Pipeline Products by Stage of Development
      • Table Figure 1: Total Artificial Heart - Pipeline Products by Stage of Development
      • Table Total Artificial Heart - Pipeline Products by Stage of Development
    • Total Artificial Heart - Pipeline Products by Territory
      • Table Figure 2: Total Artificial Heart - Pipeline Products by Territory
      • Table Total Artificial Heart - Pipeline Products by Territory
    • Total Artificial Heart - Pipeline Products by Regulatory Path
      • Table Figure 3: Total Artificial Heart - Pipeline Products by Regulatory Path
      • Table Total Artificial Heart - Pipeline Products by Regulatory Path
    • Total Artificial Heart - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Total Artificial Heart - Pipeline Products by Estimated Approval Date
      • Table Total Artificial Heart - Pipeline Products by Estimated Approval Date
    • Total Artificial Heart - Ongoing Clinical Trials
      • Table Figure 5: Total Artificial Heart - Ongoing Clinical Trials
      • Table Total Artificial Heart - Ongoing Clinical Trials
  • Total Artificial Heart - Pipeline Products under Development by Companies
    • Total Artificial Heart Companies - Pipeline Products by Stage of Development
      • Table Total Artificial Heart Companies - Pipeline Products by Stage of Development
    • Total Artificial Heart - Companies Pipeline Products by Stage of Development
      • Table Total Artificial Heart - Companies Pipeline Products by Stage of Development
  • Total Artificial Heart Companies and Product Overview
    • Abiomed Inc Company Overview
      • Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AbioCor II - Product Status
        • Table AbioCor II - Product Description
    • Aerospace Taixin Technology Co Ltd Company Overview
      • Aerospace Taixin Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aerospace Taixin Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HeartCon II - Product Status
        • Table HeartCon II - Product Description
    • BioLife4D Corp Company Overview
      • BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mini-Heart - Product Status
        • Table Mini-Heart - Product Description
        • Table Viable Heart - Product Status
        • Table Viable Heart - Product Description
    • BiVacor Pty Ltd Company Overview
      • BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BiVACOR Device - Product Status
        • Table BiVACOR Device - Product Description
        • Table BiVacor Pty Ltd - Ongoing Clinical Trials Overview
        • Table BiVACOR Device - BiVACOR Total Artificial Heart Early Feasibility Study
    • Carmat SAS Company Overview
      • Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aeson - Product Status
        • Table Aeson - Product Description
        • Table Carmat SAS - Ongoing Clinical Trials Overview
        • Table Aeson - Multicentric Prospective Cohort Study in Patients with Irreversible Biventricular Heart Failure to Assess the Efficacy and Safety of Carmat TAH, Its Clinical Utility and Cost, as a Bridge to Transplantation
    • Cleveland Clinic Lerner College of Medicine Company Overview
      • Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Continuous-Flow Total Artificial Heart - Product Status
        • Table Continuous-Flow Total Artificial Heart - Product Description
        • Table Pediatric Continuous-Flow Total Artificial Heart - Product Status
        • Table Pediatric Continuous-Flow Total Artificial Heart - Product Description
    • Cleveland Heart Inc Company Overview
      • Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SmartHeart TAH - Product Status
        • Table SmartHeart TAH - Product Description
    • Collplant Biotechnologies Ltd Company Overview
      • Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3D Printed Heart - Product Status
        • Table 3D Printed Heart - Product Description
    • CoRISMA MCS Systems Inc Company Overview
      • CoRISMA MCS Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CoRISMA MCS Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CoRISMA - Product Status
        • Table CoRISMA - Product Description
    • Foster-Miller Inc (Inactive) Company Overview
      • Foster-Miller Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Foster-Miller Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Magscrew Total Artificial Heart - Product Status
        • Table Magscrew Total Artificial Heart - Product Description
    • Griffith University Company Overview
      • Griffith University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Griffith University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Artificial Heart - Product Status
        • Table Next Generation Artificial Heart - Product Description
    • Lausanne University Hospital Company Overview
      • Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lausanne University Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table RollingHeart - Product Status
        • Table RollingHeart - Product Description
    • OregonHeart Inc (Inactive) Company Overview
      • OregonHeart Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table OregonHeart Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Total Artificial Heart - Product Status
        • Table Next Generation Total Artificial Heart - Product Description
    • ReliantHeart, Inc. Company Overview
      • ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pulse Less Total Artificial Heart - Product Status
        • Table Pulse Less Total Artificial Heart - Product Description
    • Scandinavian Real Heart AB Company Overview
      • Scandinavian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Scandinavian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Realheart TAH - Product Status
        • Table Realheart TAH - Product Description
        • Table Total Artificial Heart - Clinical Version - Product Status
        • Table Total Artificial Heart - Clinical Version - Product Description
    • Shanghai Xinhengrui Medical Technology Co Ltd Company Overview
      • Shanghai Xinhengrui Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shanghai Xinhengrui Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Total Artificial Heart - Product Status(Shanghai Xinhengrui Medical Technology Co Ltd)
        • Table Total Artificial Heart - Product Description(Shanghai Xinhengrui Medical Technology Co Ltd)
    • Suzhou Xinqing Medical Technology Co Ltd Company Overview
      • Suzhou Xinqing Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Suzhou Xinqing Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MoyoAssist - Product Status
        • Table MoyoAssist - Product Description
        • Table NyokAssist Percutaneous VAD - Product Status
        • Table NyokAssist Percutaneous VAD - Product Description
    • Syncardia Systems LLC Company Overview
      • Syncardia Systems LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Syncardia Systems LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table SynCardia 50cc Temporary Total Artificial Heart - Destination Therapy - Product Status
        • Table SynCardia 50cc Temporary Total Artificial Heart - Destination Therapy - Product Description
        • Table SynCardia 70cc Temporary Total Artificial Heart - Destination Therapy - Product Status
        • Table SynCardia 70cc Temporary Total Artificial Heart - Destination Therapy - Product Description
    • University of New South Wales Company Overview
      • University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of New South Wales Pipeline Products & Ongoing Clinical Trials Overview
        • Table Total Artificial Heart - Product Status(University of New South Wales)
        • Table Total Artificial Heart - Product Description(University of New South Wales)
    • University of Tokyo Company Overview
      • University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview
        • Table Helical Flow Total Artificial Heart - Product Status
        • Table Helical Flow Total Artificial Heart - Product Description
  • Total Artificial Heart- Recent Developments
    • Feb 20, 2024: Revolutionary Artificial Heart a Lifeline for Heart Failure Patients
    • Feb 20, 2024: BiVACOR Receives $13 Million to Support Clinical Trials for the Company's Total Artificial Heart
    • Feb 06, 2024: Realheart Appoints Andreas Hultdin as Interim CFO Following the Resignation of Jonas Caspari Bark
    • Feb 05, 2024: Syncardia Systems Announces Publication of Patent Application Covering Innovative Total Artificial Heart Design
    • Jan 15, 2024: CARMAT Achieves a Pivotal Year in 2023 by Reaching the Milestone of 50 Implants of the Aeson Artificial Heart and Presents Its Development Prospects
    • Dec 28, 2023: Carmat Announces a Software Enhancement which Significantly Improves the Safety Profile of its Aeson Artificial Heart
    • Dec 27, 2023: BiVacor Names Axonics CEO as Chair of its Board
    • Dec 11, 2023: Carmat Announces the First Implant of the Aeson Artificial Heart in a Patient Suffering from a Cardiac Tumor
    • Nov 30, 2023: BiVACOR wins IDE to start first-in-human study for artificial heart
    • Nov 29, 2023: magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases
    • Nov 21, 2023: National Heart Centre Singapore partners Mede
    • Nov 16, 2023: Scandinavian Real Heart: Interim Report July to September 2023
    • Nov 13, 2023: Realheart Provides an Update on the Development and Commercialization of Its Artificial Heart
    • Nov 01, 2023: Realheart has Successfully Established a Novel Test System to Evaluate Hemolysis of its Total Artificial Heart
    • Sep 25, 2023: CARMAT Reports its 2023 Half-Year Results and Provides an Update on its Strategic Progress
    • Sep 05, 2023: First Patient With Nyokassist Interventional Ventricular Assist Device: Dr. Junbo Ge's Team Successfully Completed the First High-Risk PCI Treatment Supported by the New Generation of Interventional VAD
    • Aug 30, 2023: Stuart McConchie Appointed Adjunct Board Member to Realheart
    • Aug 24, 2023: Scandinavian Real Heart Announces Interim Report 2023
    • Aug 23, 2023: Realheart's CEO to Speak at China Heart Congress
    • Aug 22, 2023: magAssist's ventricular pump scores FDA breakthrough designation
    • Aug 10, 2023: Magnus Ohman Appointed Adjunct Board Member to Realheart
    • Jul 11, 2023: SynCardia Updates Total Artificial Heart Labeling with Real World Data
    • Jun 28, 2023: Realheart Gets Go-Ahead for International Trademark Protection
    • Jun 15, 2023: Cardiac Surgeon Dilek Gursoy Speaks About Realheart's Artificial Heart at Impact LECH
    • Jun 14, 2023: Scandinavian Real Heart Announces Bulletin from the Annual General Meeting held on 14 June 2023
    • Jun 08, 2023: Realheart Part of Vinnova Project for Cordless TAH Technology
    • May 24, 2023: Realheart Releases the Annual Report for 2022
    • May 03, 2023: Scientists at Scandinavian Real Heart and at the University of Bath Publish the World's First Computer Simulation Method for Dual Mechanical Heart Valves in Series
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings